Medrx Co.,Ltd. Logo

Medrx Co.,Ltd.

Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.

4586 | T

Overview

Corporate Details

ISIN(s):
JP3921220004
LEI:
Country:
Japan
Address:
東かがわ市西山431番地7
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Medrx Co., Ltd., established in 2002, is a pharmaceutical company focused on drug formulation development. The company specializes in creating new dosage forms and value-added medicines, with a core technological expertise in transdermal absorption and drug delivery systems. Medrx conducts research and development to create innovative pharmaceutical candidates, which it then licenses to other companies for final clinical trials, production, and commercialization. The company's primary goal is to improve global health and patient quality of life by developing medications that offer alternatives to conventional oral administration, thereby improving patient adherence and therapeutic effectiveness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 08:33
Interim Report
確認書
Japanese 8.9 KB
2025-08-08 08:31
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 425.8 KB
2025-06-13 08:31
Share Issue/Capital Change
臨時報告書
Japanese 39.1 KB
2025-03-31 08:33
Governance Information
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 08:32
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 08:32
Post-Annual General Meeting Information
臨時報告書
Japanese 25.0 KB
2025-03-31 08:32
Registration Form
訂正有価証券届出書(組込方式)
Japanese 271.6 KB
2025-03-31 08:31
Registration Form
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.4 MB
2025-03-28 07:31
Registration Form
訂正有価証券届出書(組込方式)
Japanese 268.0 KB
2025-03-25 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 409.6 KB
2024-08-09 08:01
Interim Report
確認書
Japanese 8.8 KB
2024-08-09 08:00
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 345.0 KB
2024-05-17 08:01
Share Issue/Capital Change
臨時報告書
Japanese 39.2 KB
2024-05-10 08:02
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-05-10 08:01
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 408.3 KB

Automate Your Workflow. Get a real-time feed of all Medrx Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medrx Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medrx Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan
7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan
9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece
INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland
INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea
216400
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL

Talk to a Data Expert

Have a question? We'll get back to you promptly.